- Published
- 23 July 2021
- Letter
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
- Authors
-
- Source
- Blood
Full text
Abstract
No abstract available
Rights
This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.
Cite as
Roeker, L., Eyre, T., Thompson, M., Lamanna, N., Coltoff, A., Davids, M., Baker, P., Leslie, L., Rogers, K., Allan, J., Cordoba, R., Lopez-Garcia, A., Antic, D., Pagel, J., Martinez-Calle, N., Garcia-Marco, J., Hernández-Rivas, J., Miras, F., Coombs, C., Österborg, A., Seddon, A., López-Jiménez, J., Wilson, M., El-Sharkawi, D., Wojenski, D., Ma, S., Munir, T., Valenciano, S., Seymour, E., Barr, P., Pu, J., Patten, P., Perini, G., Huntington, S., Parry, H., Sundaram, S., Skarbnik, A., Kamdar, M., Jacobs, R., Walter, H., Walewska, R., Broom, A., Lebowitz, S., Isaac, K., Portell, C., Ahn, I., Ujjani, C., Shadman, M., Skånland, S., Chong, E. & Mato, A. 2021, 'COVID-19 in patients with CLL: improved survival outcomes and update on management strategies', Blood. https://doi.org/10.1182/blood.2021011841
Downloadable citations
Download HTML citationHTML Download BIB citationBIB Download RIS citationRISIdentifiers
- Repository URI
- http://eprints.gla.ac.uk/249933/